Synlogic Provides Corporate Update and Outlook for 2023

January 5, 2023

https://www.globenewswire.com/news-release/2023/01/05/2583497/0/en/Synlogic-Provides-Corporate-Update-and-Outlook-for-2023.html

Pivotal Phase 3 for SYNB1934 in phenylketonuria (PKU) to initiate in H1 2023

Rare Pediatric Disease Designation received for SYNB1353 for homocystinuria (HCU)

Read more at globenewswire.com

Related news for (SYBX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.